Benzinga · Oct 13, 2026
Barclays Initiates Coverage On Chemours with Equal-Weight Rating, Announces Price Target of $16
Barclays analyst Aleksey Yefremov initiates coverage on Chemours (NYSE:CC) with a Equal-Weight rating and announces Price Target of $16.

